Analyst Ratings for MEI Pharma (MEIP) [Buys]
MEIP Rating Summary
MEIP Price Target Summary
- Highest: $7.00 (Stifel)
- Lowest: $7.00 (Stifel)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$7.00 (+116%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 48%
Rating Score: 4.7 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2020 | Brookline Capital Markets » Updated 6/6/2022 |
Leah Rush Cann | New Coverage | Buy (N/A) |
15.00 (N/A) |
3.08 (3.24) |
5.19% | Details |
| 12/2/2019 | Jones Trading | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.96 (3.24) |
65.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
